GlassScriptPhysician profile
Paul Witold Ostoya
NPI 1649318338
$1,477.79
in general payments reported to CMS, 2019-2025
16 companies · $8.16 in 2025
The $8.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $95.17 · 2021: $275 · 2022: $271 · 2025: $8.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $497.44 | 2019-2022 | |
| Hologic Sales and Service, LLC | $296.78 | 2019-2020 | |
| Abbvie INC. | $279.58 | 2019-2022 | |
| Lupin INC. | $149.78 | 2019 | |
| Evofem Biosciences, INC. | $38.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.48 | 2019-2021 | |
| Allergan, INC. | $32.78 | 2019-2020 | |
| Smith+Nephew, INC. | $26.32 | 2019 | |
| Organon LLC | $24.24 | 2022 | |
| Medicem INC. | $18.71 | 2021 | |
| Merck Sharp & Dohme LLC | $17.19 | 2021 | |
| Dysis Medical, INC. | $14.66 | 2019 | |
| Becton, Dickinson and Company | $14.21 | 2022 | |
| Agile Therapeutics, INC. | $11.77 | 2021 | |
| Myovant Sciences INC. | $11.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $8.16 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ostoya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.